Middle East Healthcare First Quarter 2024 Earnings: Misses Expectations

Simply Wall St

May 07, 2024

Middle East Healthcare (TADAWUL:4009) First Quarter 2024 Results

Key Financial Results

Revenue: ر.س689.2m (up 8.0% from 1Q 2023).
Net income: ر.س51.9m (up 3.6% from 1Q 2023).
Profit margin: 7.5% (down from 7.9% in 1Q 2023). The decrease in margin was driven by higher expenses.
EPS: ر.س0.56 (up from ر.س0.55 in 1Q 2023).

earnings-and-revenue-growth — SASE:4009 Earnings and Revenue Growth May 7th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Middle East Healthcare Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 26%.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Healthcare industry in Saudi Arabia.

Performance of the Saudi Healthcare industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Middle East Healthcare you should know about.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.